Haemostatic Profile in Patients of Myeloproliferative Neoplasms-A Tertiary Care Centre Experience

Introduction: Patients of MPN commonly present with abnormalities in laboratory coagulation tests that are consistent with hypercoagulable state. Some individuals with MPN exhibit a pattern of exclusive bleeding or thrombotic events; many others have both bleeding and thrombosis during the cours...

Full description

Bibliographic Details
Main Authors:	Yatendra Parashar, Rashmi Kushwaha, Ashutosh Kumar, Kamal Agarwal, U.S Singh, Mili Jain, S.P Verma, A.K Tripathi
Format:	Article
Language:	English
Published:	JCDR Research and Publications Private Limited 2016-11-01
Series:	Journal of Clinical and Diagnostic Research
Subjects:	haemorrhage platelet dysfunction thrombosis
Online Access:	https://jcdr.net/articles/PDF/8840/19985_CE(Ra1)_F(AK)_PF1(ROAK)_PFA(AK)_PF2(OPR_P).pdf

Similar Items

Thrombosis and hemorrhage in myeloproliferative neoplasms: The platelet perspective
by: Yiming Feng, et al.
Published: (2022-10-01)

Antiphospholipid antibodies and the risk of thrombosis in myeloproliferative neoplasms
by: Dambrauskienė Rūta, et al.
Published: (2023-02-01)

The haemostatic effect of deep-frozen platelets versus room temperature-stored platelets in the treatment of surgical bleeding: MAFOD—study protocol for a randomized controlled non-inferiority trial
by: Tim W. H. Rijnhout, et al.
Published: (2022-09-01)

THE ROLE OF JAK2 MUTATION IN THROMBOTIC COMPLICATIONS OF CHRONIC MYELOPROLIFERATIVE NEOPLASMS
by: Viola M. Popov, et al.
Published: (2014-08-01)

Platelet Function, Role in Thrombosis, Inflammation, and Consequences in Chronic Myeloproliferative Disorders
by: Lisa Repsold, et al.
Published: (2021-11-01)

Thrombosis in patients with myeloproliferative neoplasms. Case report
by: Anait L. Melikyan, et al.
Published: (2021-07-01)

Emerging Role of Neutrophils in the Thrombosis of Chronic Myeloproliferative Neoplasms
by: Francisca Ferrer-Marín, et al.
Published: (2021-01-01)

Hemorrhagic and thrombotic complications in patients with myeloproliferative diseases
by: Carla Valladares Vignal, et al.

Myeloproliferative Neoplasms and Aspirin: Does Increased Platelet Turnover Matter?
by: Ilgın Koçak Göktürk, et al.
Published: (2023-03-01)

Clinical Features of 294 Turkish Patients with Chronic Myeloproliferative Neoplasms
by: Neslihan Andıç, et al.
Published: (2016-08-01)

Endothelium state in Ph-negative myeloproliferative neoplasms
by: N. E. Korsakova
Published: (2021-12-01)

Vascular Diseases In Patients With Chronic Myeloproliferative Neoplasms – Impact Of Comorbidity
by: Frederiksen H, et al.
Published: (2019-11-01)

Does Double Mean Trouble? Coexistence of Myeloproliferative and Lymphoproliferative Neoplasms
by: Danijela Lekovic, et al.
Published: (2024-03-01)

Thrombosis in myeloproliferative neoplasms during cytoreductive and antithrombotic drug treatment
by: Tiziano Barbui, et al.
Published: (2022-01-01)

Thrombotic and haemorrhagic complications in critically ill patients with COVID-19: a multicentre observational study
by: Akshay Shah, et al.
Published: (2020-09-01)

Clinical features and diagnosis of Ph - negative myeloproliferative neoplasms occurring in conjunction with the antiphospholipid syndrome
by: A L Melikyan, et al.
Published: (2019-07-01)

Thrombosis in myeloproliferative neoplasms: A clinical and pathophysiological perspective
by: Sarah Kelliher, et al.
Published: (2021-12-01)

Patients with myeloproliferative neoplasms and COVID‐19 have increased rates of arterial thrombosis
by: Orly Leiva, et al.
Published: (2022-07-01)

Impact of platelet transfusion on outcomes in trauma patients
by: S. R. Hamada, et al.
Published: (2022-02-01)

Platelet transcriptome identifies progressive markers and potential therapeutic targets in chronic myeloproliferative neoplasms
by: Zhu Shen, et al.
Published: (2021-10-01)

Splanchnic Vein Thrombosis in Myeloproliferative Neoplasms: Treatment Considerations and Unmet Needs
by: Angela Liu, et al.
Published: (2022-12-01)

Thrombosis in myeloproliferative neoplasms: Treatment outcomes of direct oral anticoagulants and vitamin K antagonists
by: Kateryna Fedorov, et al.
Published: (2021-08-01)

Can Novel Insights into the Pathogenesis of Myeloproliferative Neoplasm-Related Thrombosis Inform Novel Treatment Approaches?
by: Ofir Wolach, et al.
Published: (2021-05-01)

Risk Factors for Death or Cardiovascular Events after Acute Coronary Syndrome in Patients with Myeloproliferative Neoplasms
by: Orly Leiva, et al.
Published: (2023-06-01)

Clinical Characteristics and Prognostic Risks of Philadelphia-Negative Myeloproliferative Neoplasms at Cipto Mangunkusumo General Hospital
by: Sukrisman L
Published: (2022-09-01)

Exploring the Molecular Aspects of Myeloproliferative Neoplasms Associated with Unusual Site Vein Thrombosis: Review of the Literature and Latest Insights
by: Erika Morsia, et al.
Published: (2024-01-01)

Patients With Myeloproliferative Neoplasms Harbor High Frequencies of CD8 T Cell-Platelet Aggregates Associated With T Cell Suppression
by: Ana Micaela Carnaz Simões, et al.
Published: (2022-05-01)

Haemostatic Parameters in Patients with Behçet’s Disease
by: Juma K. Alkaabi, et al.
Published: (2014-05-01)

Haemostatic Parameters in Patients with Behçet’s Disease
by: Juma K. Alkaabi, et al.
Published: (2014-05-01)

Polypharmacy, Potentially Inappropriate Medications, and Drug-to-Drug Interactions in Patients with Chronic Myeloproliferative Neoplasms
by: Ivan Krečak, et al.
Published: (2023-04-01)

Genetic polymorphisms of hemostatic factors and thrombotic risk in non BCR-ABL myeloproliferative neoplasms: A pilot study
by: Dambrauskienė R, et al.
Published: (2017-06-01)

Bleeding, thrombosis, and anticoagulation in myeloproliferative neoplasms (MPN): analysis from the German SAL-MPN-registry
by: A. Kaifie, et al.
Published: (2016-03-01)

Anticoagulation for Splanchnic Vein Thrombosis in Myeloproliferative Neoplasms: The Drug and the Duration
by: Wafik G. Sedhom, et al.
Published: (2021-05-01)

Molecular Studies for the Early Detection of Philadelphia-Negative Myeloproliferative Neoplasms
by: Ruth Stuckey, et al.
Published: (2023-08-01)

Corrigendum: Patients with myeloproliferative neoplasms harbor high frequencies of CD8 T cell-platelet aggregates associated with T cell suppression
by: Ana Micaela Carnaz Simões, et al.
Published: (2022-08-01)

Mechanisms of platelet activation in cancer-associated thrombosis: a focus on myeloproliferative neoplasms
by: Roelof H. Bekendam, et al.
Published: (2023-06-01)

Thrombotic and hemorrhagic events in 2016 World Health Organization-defined Philadelphia-negative myeloproliferative neoplasm
by: Ik-Chan Song, et al.
Published: (2021-09-01)

Romiplostim – an emergency treatment of intracranial haemorrhage in the course of severe primary immune thrombocytopaenia
by: Paweł Łaguna, et al.
Published: (2022-12-01)

The Increase of The Mean Platelet Volume in Patients With Intracerebral Haemorrhage
by: Adalet Arıkanoğlu, et al.
Published: (2012-06-01)

The Increase of The Mean Platelet Volume in Patients With Intracerebral Haemorrhage
by: Adalet Arıkanoğlu, et al.
Published: (2012-06-01)